Comparing Nu Skin Enterprises (NYSE:NUS) & Medifast (NYSE:MED)

Medifast (NYSE:MED) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Profitability

This table compares Medifast and Nu Skin Enterprises’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medifast	-8.08%	-6.69%	-5.25%
Nu Skin Enterprises	-15.73%	6.58%	3.63%

Analyst Recommendations

This is a summary of current ratings for Medifast and Nu Skin Enterprises, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1	2	0	0	1.67
Nu Skin Enterprises	2	0	0	0	1.00

Medifast currently has a consensus target price of $12.00, suggesting a potential upside of 4.44%. Given Medifast’s stronger consensus rating and higher probable upside, research analysts clearly believe Medifast is more favorable than Nu Skin Enterprises.

Earnings and Valuation

This table compares Medifast and Nu Skin Enterprises”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79 million	0.33	-$18.67 million	($2.33)	-4.93
Nu Skin Enterprises	$1.49 billion	0.15	$160.20 million	($4.47)	-1.04

Nu Skin Enterprises has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

95.5% of Medifast shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 3.7% of Medifast shares are owned by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Medifast has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500.

Summary

Medifast beats Nu Skin Enterprises on 7 of the 13 factors compared between the two stocks.

About Medifast

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.